୩୪ କର୍କଟ trial ରୋଗୀ ନେଉଛି Delhi NCR ରେ
ClinicalTrials.gov ରୁ, ୨୦ ଅକ୍ଟୋବର ୨୦୨୬ ରେ ପଢ଼ାଯାଇଛି। ବିବରଣୀ ବଦଳିପାରେ, ତେଣୁ ସବୁବେଳେ hospital ସହିତ confirm କରନ୍ତୁ। Filter this list
ରକ୍ତ କର୍କଟ · Delhi NCR
ବ୍ଲଡ୍ କ୍ୟାନ୍ସର (AML ଲ୍ୟୁକେମିଆ)
ଗୋଟିଏ ଔଷଧ ପରୀକ୍ଷା
ବୟସ୍କ18+ ବର୍ଷଫେଜ୍ 4
Study to Assess Adverse Events and Change in Disease Activity of Oral Venetoclax in Combination With Subcutaneous (SC) o
All India Institute Of Medical Sciences - New DelhiNew Delhi · ଏବଂ ୧୦ ଅଧିକ
ରକ୍ତ କର୍କଟ · Delhi NCR
ହଜକିନ ଲିମ୍ଫୋମା
ଗୋଟିଏ ଔଷଧ ପରୀକ୍ଷା
ବୟସ୍କ18+ ବର୍ଷଫେଜ୍ 4
A Study of Brentuximab Vedotin With Doxorubicin, Vinblastine and Dacarbazine in Adults With Hodgkin Lymphoma in India
AIIMSNew Delhi · ଏବଂ ୪ ଅଧିକ
ରକ୍ତ କର୍କଟ · Delhi NCR
ଲିମ୍ଫୋମା
ଗୋଟିଏ ଔଷଧ ପରୀକ୍ଷା
ବୟସ୍କ18–99 ବର୍ଷଫେଜ୍ 1
A Study Evaluating the Safety and Efficacy of AUR108 in Patients With Relapsed Advanced Lymphomas (ASHA-1)
Rajiv Gandhi Cancer Institute and Research CentreDelhi · ଏବଂ ୨୫ ଅଧିକ
ରକ୍ତ କର୍କଟ · Delhi NCR
ଲିମ୍ଫୋମା
ଗୋଟିଏ ଔଷଧ ପରୀକ୍ଷା
ବୟସ୍କ18–99 ବର୍ଷଫେଜ୍ 1
Study Evaluating Safety Pharmacokinetics and Pharmacodynamics of AUR112 in Patients With Relapsed Advanced Lymphoma
National Cancer Institute , All India Institute of Medical SciencesJhajjar · ଏବଂ ୧୧ ଅଧିକ
ରକ୍ତ କର୍କଟ · Delhi NCR
ମାଇଲୋଡିସପ୍ଲାଷ୍ଟିକ୍ ସିଣ୍ଡ୍ରୋମ୍
ଗୋଟିଏ ଔଷଧ ପରୀକ୍ଷା
ବୟସ୍କ18+ ବର୍ଷଫେଜ୍ 3
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS
All India Institute of Medical ScienceNew Delhi · ଏବଂ ୭ ଅଧିକ
ରକ୍ତ କର୍କଟ · Delhi NCR
ମାଇଲୋମା
ଗୋଟିଏ ଔଷଧ ପରୀକ୍ଷା
ବୟସ୍କ18+ ବର୍ଷଫେଜ୍ 3
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Rajiv Gandhi Cancer Institute and Research CentreNew Delhi · ଏବଂ ୬ ଅଧିକ
ରକ୍ତ କର୍କଟ · Delhi NCR
ମାଇଲୋମା
ଗୋଟିଏ ଔଷଧ ପରୀକ୍ଷା
ବୟସ୍କ18+ ବର୍ଷଫେଜ୍ 3
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone
Marengo Asia Hospitals GurugramGurugram · ଏବଂ ୫ ଅଧିକ
ରକ୍ତ କର୍କଟ · Delhi NCR
ବିରଳ ରକ୍ତ କର୍କଟ (BPDCN)
ଯତ୍ନ ଦେଖେ, ନୂଆ ଚିକିତ୍ସା ନାହିଁ
ପିଲା ଏବଂ ବୟସ୍କObservational
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry
Department of Medical Oncology, Dr. B.R.A Institute Rotary Cancer Hospital, All India Institute of Medical Sciencesନୂଆ ଦିଲ୍ଲୀ
ହାଡ଼ ଏବଂ ଚର୍ମ · Delhi NCR
ହାଡ଼ ଟ୍ୟୁମର (giant cell)
ଗୋଟିଏ ଔଷଧ ପରୀକ୍ଷା
ବୟସ୍କ18+ ବର୍ଷଫେଜ୍ 3
Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone
All India Institute of Medical Scienceନୂଆ ଦିଲ୍ଲୀ
ମସ୍ତିଷ୍କ · Delhi NCR
ବ୍ରେନ୍ ଟ୍ୟୁମର (ଏମ୍ବ୍ରିଓନାଲ୍)
ଯତ୍ନ ଦେଖେ, ନୂଆ ଚିକିତ୍ସା ନାହିଁ
ପିଲା ଏବଂ ବୟସ୍କ୧ ଦିନ–୨୫ ବର୍ଷObservational
Rare Embryonal Tumors of the Central Nervous System: International Registry
National Cancer Institute, All India Institutes of Medical Sciencesନୂଆ ଦିଲ୍ଲୀ
ସ୍ତନ · Delhi NCR
ସ୍ତନ କ୍ୟାନ୍ସର
ଗୋଟିଏ ଔଷଧ ପରୀକ୍ଷା
ବୟସ୍କ18+ ବର୍ଷଫେଜ୍ 3
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive,
Artemis hospitalGurugram · ଏବଂ ୯ ଅଧିକ
ସର୍ଭିକ୍ସ ଏବଂ ଗର୍ଭାଶୟ · Delhi NCR
ସର୍ଭିକାଲ୍ କ୍ୟାନ୍ସର
ରେଡିଏସନ୍ ପରୀକ୍ଷା
ମହିଳା୧୮–୬୫ ବର୍ଷNot phased
HYPOfractionated RadioTherapy in Cervical Cancer
National Cancer Institute, All India Institute of Medical Sciences, New Delhi, Indiaନୂଆ ଦିଲ୍ଲୀ
ମୁଣ୍ଡ ଏବଂ ବେକ · Delhi NCR
ମୁଣ୍ଡ ଓ ବେକ କ୍ୟାନ୍ସର
ଏକ ଔଷଧ ଏବଂ ରେଡିଏସନର ଟେଷ୍ଟ
ପ୍ରାପ୍ତବୟସ୍କ60+ ବର୍ଷପର୍ଯ୍ୟାୟ 3
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
Rajiv Gandhi Cancer Institute and Research CentreNew Delhi · ଏବଂ ୪ ଅଧିକ
ମୁଣ୍ଡ ଏବଂ ବେକ · Delhi NCR
ମୁଣ୍ଡ ଓ ବେକ କ୍ୟାନ୍ସର
ଟେଷ୍ଟ ରେଡିଏସନ୍ ଏବଂ ଏକ ଔଷଧ
ବୟସ୍କ18–70 ବର୍ଷPhase 3
A Trial Evaluating Omission of Radiotherapy to Regional Lymphatic's
Nci, Aiimsଝାଝର
ମୁଣ୍ଡ ଏବଂ ବେକ · Delhi NCR
ମୁଣ୍ଡ ଓ ବେକ କ୍ୟାନ୍ସର
ଟେଷ୍ଟ ରେଡିଏସନ୍ ଏବଂ ଏକ ଔଷଧ
ବୟସ୍କ18–70 ବର୍ଷPhase 3
The SWOAR Trial Sparing of Swallowing and Aspiration Related Organs at Risk & Submandibular Gland With Intensity Modulat
Nci, Aiimsଝାଝର
ମୁଣ୍ଡ ଏବଂ ବେକ · Delhi NCR
ମୁଣ୍ଡ ଓ ବେକ କ୍ୟାନ୍ସର
ଟେଷ୍ଟ ରେଡିଏସନ୍ ଏବଂ ଏକ ଔଷଧ
ବୟସ୍କ18–70 ବର୍ଷPhase 2
Dose Escalation Using Hypoxia-adjusted Radiotherapy
Rajiv Gandhi Cancer Institute and Research Centreଦିଲ୍ଲୀ
ମୁଣ୍ଡ ଏବଂ ବେକ · Delhi NCR
ମୁଣ୍ଡ ଓ ବେକ କ୍ୟାନ୍ସର
ଗୋଟିଏ ଔଷଧ ପରୀକ୍ଷା
ବୟସ୍କ18+ ବର୍ଷଫେଜ୍ 3
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurre
All India Institute of Medical SciencesNew Delhi · ଏବଂ 5 ଅଧିକ
ଲିଭର ଓ ପ୍ୟାନକ୍ରିଆସ · ଦିଲ୍ଲୀ NCR
ପିତ୍ତନଳୀ କର୍କଟ
ଯତ୍ନ ଦେଖେ, ନୂଆ ଚିକିତ୍ସା ନାହିଁ
ବୟସ୍କ18+ ବର୍ଷଅବଜରଭେସନାଲ
The Study of Association of Helicobacter Infections in Biliary Tract Cancers
ILBSନୂଆ ଦିଲ୍ଲୀ
ଲିଭର ଓ ପ୍ୟାନକ୍ରିଆସ · ଦିଲ୍ଲୀ NCR
ପିତ୍ତନଳୀ କର୍କଟ
ଯତ୍ନ ଦେଖେ, ନୂଆ ଚିକିତ୍ସା ନାହିଁ
ବୟସ୍କ18+ ବର୍ଷଅବଜରଭେସନାଲ
To Revisit the Yield of Staging Laparoscopy in Hepatopancreatobiliary Malignancies
Institute of Liver and Biliary Sciencesନୂଆ ଦିଲ୍ଲୀ
ଲିଭର ଓ ପ୍ୟାନକ୍ରିଆସ · ଦିଲ୍ଲୀ NCR
ପିତ୍ତକୋଷ କର୍କଟ
ଗୋଟିଏ ଔଷଧ ଏବଂ ସର୍ଜରୀ କିମ୍ବା ଏକ ପ୍ରକ୍ରିୟା ପରୀକ୍ଷା କରେ
ବୟସ୍କ18–70 ବର୍ଷPhase 3
Neoadjuvant Chemotherapy for Locally Advanced Gall Bladder Cancer : a Randomized Control Trial (NEOGB)
Rajiv Gandhi Cancer Institute and Research Centreଦିଲ୍ଲୀ · ଏବଂ 2 ଅଧିକ
ଲିଭର ଓ ପ୍ୟାନକ୍ରିଆସ · ଦିଲ୍ଲୀ NCR
ପ୍ୟାଙ୍କ୍ରିଆଟିକ୍ କ୍ୟାନ୍ସର୍
ଗୋଟିଏ ଔଷଧ ପରୀକ୍ଷା
ବୟସ୍କ18+ ବର୍ଷଫେଜ୍ 3
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Signif
Venkateshwar HospitalNew Delhi · ଏବଂ ୪ ଅଧିକ
ଫୁସଫୁସ · ଦିଲ୍ଲୀ NCR
ଫୁସଫୁସ କ୍ୟାନ୍ସର
ଗୋଟିଏ ଔଷଧ ପରୀକ୍ଷା
ବୟସ୍କ18+ ବର୍ଷଫେଜ୍ 1
First in Human Multicenter Open Name Dose-increase, Consolidation Method to Study Safety Drug-level in Blood & Drug Meta
All India Institute of Medical Sciences(AIIMS)New Delhi · ଏବଂ 5 ଅଧିକ
ଫୁସଫୁସ · ଦିଲ୍ଲୀ NCR
ଫୁସଫୁସ କ୍ୟାନ୍ସର (ନନ୍-ସ୍ମଲ୍ ସେଲ୍)
ଗୋଟିଏ ଔଷଧ ପରୀକ୍ଷା
ବୟସ୍କ18+ ବର୍ଷଫେଜ୍ 3
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adu
Artemis hospitalଗୁରୁଗ୍ରାମ · ଏବଂ 14 ଅଧିକ
ଫୁସଫୁସ · ଦିଲ୍ଲୀ NCR
ଫୁସଫୁସ କ୍ୟାନ୍ସର (ନନ୍-ସ୍ମଲ୍ ସେଲ୍)
ଗୋଟିଏ ଔଷଧ ପରୀକ୍ଷା
ବୟସ୍କ18+ ବର୍ଷଫେଜ୍ 3
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Venkateshwar HospitalNew Delhi · ଏବଂ 5 ଅଧିକ
ଫୁସଫୁସ · ଦିଲ୍ଲୀ NCR
ଫୁସଫୁସ କ୍ୟାନ୍ସର (ନନ୍-ସ୍ମଲ୍ ସେଲ୍)
ଗୋଟିଏ ଔଷଧ ପରୀକ୍ଷା
ବୟସ୍କ18+ ବର୍ଷଫେଜ୍ 3
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participan
All India Institute of Medical SciencesNew Delhi · ଏବଂ 12 ଅଧିକ
ଫୁସଫୁସ · ଦିଲ୍ଲୀ NCR
ଫୁସଫୁସ କ୍ୟାନ୍ସର (ନନ୍-ସ୍ମଲ୍ ସେଲ୍)
ଗୋଟିଏ ଔଷଧ ପରୀକ୍ଷା
ବୟସ୍କ18+ ବର୍ଷଫେଜ୍ 3
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combina
Indraprastha Apollo HospitalsNew Delhi · ଏବଂ 12 ଅଧିକ
ଫୁସଫୁସ · ଦିଲ୍ଲୀ NCR
ଫୁସଫୁସ କ୍ୟାନ୍ସର (ନନ୍-ସ୍ମଲ୍ ସେଲ୍)
ଗୋଟିଏ ଔଷଧ ପରୀକ୍ଷା
ବୟସ୍କ18+ ବର୍ଷଫେଜ୍ 3
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Sta
All India Institute of Medical SciencesNew Delhi · ଏବଂ ୭ ଅଧିକ
ଫୁସଫୁସ · ଦିଲ୍ଲୀ NCR
ଫୁସଫୁସ କ୍ୟାନ୍ସର (ନନ୍-ସ୍ମଲ୍ ସେଲ୍)
ଗୋଟିଏ ଔଷଧ ପରୀକ୍ଷା
ବୟସ୍କ18+ ବର୍ଷଫେଜ୍ 3
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Rajiv Gandhi Cancer Institute And Research CentreNew Delhi · ଏବଂ 5 ଅଧିକ
ଫୁସଫୁସ · ଦିଲ୍ଲୀ NCR
ଫୁସଫୁସ କର୍କଟ (ସ୍ମଲ୍ ସେଲ୍)
ଗୋଟିଏ ଔଷଧ ପରୀକ୍ଷା
ବୟସ୍କ18+ ବର୍ଷଫେଜ୍ 2
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult
Rajiv Gandhi Cancer Institute And Research CentreNew Delhi · ଏବଂ 1 ଅଧିକ
ପ୍ରୋଷ୍ଟେଟ ଓ ବ୍ଲାଡର · ଦିଲ୍ଲୀ NCR
ପ୍ରୋଷ୍ଟେଟ୍ କ୍ୟାନ୍ସର
ଗୋଟିଏ ଔଷଧ ପରୀକ୍ଷା
ପୁରୁଷ18+ ବର୍ଷଫେଜ୍ 4
A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Add
Rajiv Gandhi Cancer Institute & Research CentreNew Delhi · ଏବଂ ୭ ଅଧିକ
ପେଟ ଓ ଅନ୍ତନାଳୀ · ଦିଲ୍ଲୀ NCR
ମଳାଶୟ କର୍କଟ
ଗୋଟିଏ ଔଷଧ ପରୀକ୍ଷା
ବୟସ୍କ18+ ବର୍ଷଫେଜ୍ 3
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild
Rajiv Gandhi Cancer Institute and Research Centreଦିଲ୍ଲୀ · ଏବଂ 7 ଅଧିକ
ପେଟ ଓ ଅନ୍ତନାଳୀ · ଦିଲ୍ଲୀ NCR
ମଳାଶୟ କର୍କଟ
ଗୋଟିଏ ଔଷଧ ପରୀକ୍ଷା
ବୟସ୍କ18+ ବର୍ଷଫେଜ୍ 3
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Parti
Rajiv Gandhi Cancer Institute and Research Centreଦିଲ୍ଲୀ · ଏବଂ 4 ଅଧିକ
ଅନ୍ୟ କ୍ୟାନସର · ଦିଲ୍ଲୀ NCR
ଆଡଭାନ୍ସଡ୍ ସଲିଡ୍ ଟ୍ୟୁମର୍
ଗୋଟିଏ ଔଷଧ ପରୀକ୍ଷା
ବୟସ୍କ18+ ବର୍ଷଫେଜ୍ 1
A Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1)
Max Super Speciality HospitalNew Delhi · ଏବଂ 33 ଅଧିକ
ଅନ୍ୟ କ୍ୟାନସର · ଦିଲ୍ଲୀ NCR
ଆଡଭାନ୍ସଡ୍ ସଲିଡ୍ ଟ୍ୟୁମର୍
ଗୋଟିଏ ଔଷଧ ପରୀକ୍ଷା
ବୟସ୍କ18+ ବର୍ଷଫେଜ୍ 1
A Study to Test the Safety and Tolerability of SBO-154 in Patients With Advanced Solid Tumors.
All India Institute for Medical Sciencesଦିଲ୍ଲୀ · ଏବଂ 3 ଅଧିକ